Procurement Summary
Country: Argentina
Summary: Urgent Acquisition of Inputs - Annex Ii
Deadline: 19 Nov 2025
Posting Date: 18 Nov 2025
Other Information
Notice Type: Tender
TOT Ref.No.: 130319702
Document Ref. No.: 401-1793-CDI25
Financier: Self Financed
Purchaser Ownership: Public
Tender Value: ARS 266218239.20
Purchaser's Detail
Name: Login to see tender_details
Address: Login to see tender_details
Email: Login to see tender_details
Login to see detailsTender Details
DEXMEDETOMIDINE HYDROCHLORIDE. Model: 100 µg/ml, injectable, in vial bottle x 2 ml, OCTREOTIDE ACETATE. Model: 0.10 mg/ml, injectable, in ampoule x 1 ml, FOSFOMICINA SODIA. Model: 1, 000 mg, injectable, in vial, intravenous use, TIROFIBAN. Model: 0.25 mg/ml (As Hydrochloride Monohydrate), injectable, in a 50 ml vial, CASPOFUNGIN 70 mg. Model: Caspofungin Acetate 83.9 mg (equivalent to 75.6 mg of anhydrous free acid), injectable, lyophilized, in vial, use intravenous, HUMAN FIBRINOGEN. Model: 1000 mg, injectable, lyophilized, in a vial + solvent, with disposable infusion equipment, FLOROGLUCINOL + TRIMETHOXYBENZENE. Model: 40 mg of Phloroglucinol + 40 mg of 1, 3, 5 Trimethoxybenzene, injectable, in vial bottle, SPIRAMYCIN. Model: 1000 mg, tablet
File number: EX-2025-47556675- -GCABA-DGACSA Legal framework: Law N? 2, 095 (Consolidated Text by Law No. 6, 588) and Decree No. 129/23 Art. 29 Other conditions: Requires technical advice Responsible area: Technical Support Operational Deputy Manager More info: Place of receipt of physical documentation: Rivadavia 524, 4th floor, DGACSA Office
Documents
Tender Notice